Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000373:Agglutinins / Q000032:analysis; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000907:Antibodies, Bacterial / Q000032:analysis; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007825:Laryngectomy; D007827:Laryngitis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010031:Otitis / Q000628:therapy; D010038:Otorhinolaryngologic Diseases / Q000628:therapy*; D010612:Pharyngitis / Q000628:therapy; D011552:Pseudomonas Infections / Q000628:therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000276:immunology*; D013530:Surgical Wound Infection / Q000628:therapy
D000373:Agglutinins; D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines